Chinese Journal of Stroke ›› 2018, Vol. 13 ›› Issue (12): 1301-1308.DOI: 10.3969/j.issn.1673-5765.2018.12.016
Previous Articles Next Articles
Received:
2018-04-25
Online:
2018-12-20
Published:
2018-12-20
梁志刚,杨绍婉,于国平
通讯作者:
梁志刚 zgliang@hotmail.com
基金资助:
烟台市科技发展计划项目(2013WS022)
烟台市重点研发项目(2018SFGY092)
LIANG Zhi-Gang, YANG Shao-Wan, YU Guo-Ping. Progress of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Ischemic Stroke[J]. Chinese Journal of Stroke, 2018, 13(12): 1301-1308.
梁志刚, 杨绍婉, 于国平. 缺血性卒中静脉溶栓后症状性颅内出血研究进展[J]. 中国卒中杂志, 2018, 13(12): 1301-1308.
[1] National Institute of Neurological Disordersand Stroke rt-PA Stroke Study Group. Tissueplasminogen activator for acute ischemic stroke[J].N Engl J Med,1995,333(24):1581-1587.[2] The NINDS t-PA Stroke Study Group. Intracerebralhemorrhage after intravenous t-PA therapy forischemic stroke. The NINDS t-PA Stroke StudyGroup[J]. Stroke,1997,28(11):2109-2118.[3] HACKE W,KASTE M,BLUHMKI E,et al.Thrombolysis with alteplase 3 to 4. 5 hours afteracute ischemic stroke[J]. N Engl J Med,2008,359(13):1317-1329.[4] MIKULIK R,WAHLGREN N. Treatment of acutestroke:an update[J]. J Intern Med,2015,278(2):145-165.[5] HAMANN G F,DEL ZOPPO G J,VON KUMMERR. Hemorrhagic transformation of cerebralinfarction--possible mechanisms[J]. ThrombHaemost,1999,82(Suppl 1):92-94.[6] YAGHI S,EISENBERGER A,WILLEY J Z.Symptomatic intracerebral hemorrhage in acuteischemic stroke after thrombolysis with intravenousrecombinant tissue plasminogen activator:a reviewof natural history and treatment[J]. JAMA Neurol,2014,71(9):1181-1185.[7] HORSTMANN S,KALB P,KOZIOL J,et al.Profiles of matrix metalloproteinases,their inhibitors,and laminin in stroke patients:influence of differenttherapies[J]. Stroke,2003,34(9):2165-2170.[8] LARRUE V,VON KUMMER R R,MÜLLERA,et al. Risk factors for severe hemorrhagictransformation in ischemic stroke patients treatedwith recombinant tissue plasminogen activator:asecondary analysis of the European-AustralasianAcute Stroke Study(ECASS Ⅱ)[J]. Stroke,2001,32(2):438-441.[9] WAHLGREN N,AHMED N,DÁVALOS A,etal. Thrombolysis with alteplase for acute ischaemicstroke in the Safe Implementation of Thrombolysisin Stroke-Monitoring Study(SITS-MOST):anobservational study[J]. Lancet,2007,369(9558):275-282.[10] HACKE W,KASTE M,FIESCHI C,et al.Randomised double-blind placebo-controlledtrial of thrombolytic therapy with intravenousalteplase in acute ischaemic stroke(ECASS Ⅱ).Second European-Australasian Acute Stroke StudyInvestigators[J]. Lancet,1998,352(9136):1245-1251.[11] SYLAJA P N,COTE R,BUCHAN A M,et al.Thrombolysis in patients older than 80 years withacute ischaemic stroke:Canadian Alteplase forStroke Effectiveness Study[J]. J Neurol NeurosurgPsychiatry,2006,77(7):826-829.[12] BHATNAGAR P,SINHA D,PARKER R A,et al.Intravenous thrombolysis in acute ischaemic stroke:a systematic review and meta-analysis to aid decisionmaking in patients over 80 years of age[J]. J NeurolNeurosurg Psychiatry,2011,82(7):712-717.[13] IST-3 collaborative group,SANDERCOCK P,WARDLAW J M,et al. The benefits and harms ofintravenous thrombolysis with recombinant tissueplasminogen activator within 6 h of acute ischaemicstroke(the third international stroke trial [IST-3]):a randomised controlled trial[J]. Lancet,2012,379(9834):2352-2363.[14] HEMMEN T M,RAPP K S,EMOND J A,et al.Analysis of the National Institute of NeurologicalDisorders and Stroke tissue plasminogen activatorstudies following European Cooperative AcuteStroke Study III patient selection criteria[J]. J StrokeCerebrovasc Dis,2010,19(4):290-293.[15] 重组组织型纤溶酶原激活剂治疗缺血性卒中共识专家组. 临床应用重组组织型纤溶酶原激活剂静脉溶栓治疗缺血性卒中专家共识[J]. 中华内科杂志,2006,45(7):613-614.[16] CAPPELLARI M,BOVI P,MICHELETTI N,et al.The risk stratification based on the CHA2DS2-VAScmay predict the response to intravenous thrombolysisafter stroke[J]. J Neurol,2013,260(10):2681-2683.[17] KABLAU M,KREISEL S H,SAUER T,etal. Predictors and early outcome of hemorrhagictransformation after acute ischemic stroke[J].Cerebrovasc Dis,2011,32(4):334-341.[18] 郭义坤,李焰生. 急性脑梗死患者重组组织型纤溶酶原激活物静脉溶栓后脑出血[J]. 国际脑血管病杂志,2010,18(2):113-118.[19] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志,2015,48(4):246-257.[20] MOKIN M,KASS-HOUT T,KASS-HOUT O,etal. Blood pressure management and evolution ofthrombolysis-associated intracerebral hemorrhage inacute ischemic stroke[J]. J Stroke Cerebrovasc Dis,2012,21(8):852-859.[21] DEREX L,NIGHOGHOSSIAN N. Intracerebralhaemorrhage after thrombolysis for acute ischaemicstroke:an update[J]. J Neurol Neurosurg Psychiatry,2008,79(10):1093-1099.[22] KASE C S,FURLAN A J,WECHSLER L R,et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke:the PROACT Ⅱtrial[J]. Neurology,2001,57(9):1603-1610.[23] MISHRA N K,DAVIS S M,KASTE M,et al.Comparison of outcomes following thrombolytictherapy among patients with prior stroke anddiabetes in the Virtual International Stroke TrialsArchive(VISTA)[J]. Diabetes Care,2010,33(12):2531-2537.[24] BANG O Y,SAVER J L,KIM S J,et al. Collateralflow averts hemorrhagic transformation afterendovascular therapy for acute ischemic stroke[J].Stroke,2011,42(8):2235-2239.[25] JAUCH E C,SAVER J L,ADAMS H P JR,et al.Guidelines for the early management of patients withacute ischemic stroke:a guideline for healthcareprofessionals from the American Heart Association/American Stroke Association[J]. Stroke,2013,44(3):870-947.[26] SAPOSNIK G,GLADSTONE D,RAPTIS R,etal. Atrial fibrillation in ischemic stroke:predictingresponse to thrombolysis and clinical outcomes[J].Stroke,2012,44(1):99-104.[27] VERGOUWEN M D,CASAUBON L K,SWARTZR H,et al. Subtherapeutic warfarin is not associatedwith increased hemorrhage rates in ischemic strokestreated with tissue plasminogen activator[J]. Stroke,2011,42(4):1041-1045.[28] XIAN Y,LIANG L,SMITH E E,et al. Risks ofintracranial hemorrhage among patients with acuteischemic stroke receiving warfarin and treated withintravenous tissue plasminogen activator[J]. JAMA,2012,307(24):2600-2608.[29] MAZYA M,EGIDO J A,FORD G A,et al.Predicting the risk of symptomatic intracerebralhemorrhage in ischemic stroke treated withintravenous alteplase:safe Implementationof Treatments in Stroke(SITS)symptomaticintracerebral hemorrhage risk score[J]. Stroke,2012,43(6):1524-1531.[30] DORADO L,MILLÁN M,DE LA OSSA N P,et al.Influence of antiplatelet pre-treatment on the risk ofintracranial haemorrhage in acute ischaemic strokeafter intravenous thrombolysis[J]. Eur J Neurol,2010,17(2):301-306.[31] GROTTA J C,WELCH K M,FAGAN S C,et al.Clinical deterioration following improvement in theNINDS rt-PA Stroke Trial[J]. Stroke,2001,32(3):661-668.[32] GUO Y,YAN S,ZHANG S,et al. Lower serumcalcium level is associated with hemorrhagictransformation after thrombolysis[J]. Stroke,2015,46(5):1359-1361.[33] INOUE Y,MIYASHITA F,TOYODA K,et al. Lowserum calcium levels contribute to larger hematomavolume in acute intracerebral hemorrhage[J]. Stroke,2013,44(7):2004-2006.[34] HARRIS A K,ERGUL A,KOZAK A,et al. Effectof neutrophil depletion on gelatinase expression,edema formation and hemorrhagic transformationafter focal ischemic stroke[J/OL]. BMC Neurosci,2005,6:49. https://doi.org/10.1186/1471-2202-6-49.[35] ROSELL A,CUADRADO E,ORTEGA-AZNARA,et al. MMP-9-positive neutrophil infiltration isassociated to blood-brain barrier breakdown andbasal lamina type IV collagen degradation duringhemorrhagic transformation after human ischemicstroke[J]. Stroke,2008,39(4):1121-1126.[36] CASTELLANOS M,LEIRA R,SERENA J,et al.Plasma cellular-fibronectin concentration predictshemorrhagic transformation after thrombolytictherapy in acute ischemic stroke[J]. Stroke,2004,35(7):1671-1676.[37] JICKLING G C,LIU D,STAMOVA B,et al.Hemorrhagic transformation after ischemic stroke inanimals and humans[J]. J Cereb Blood Flow Metab,2014,34(2):185-199.[38] CRAIGE S M,CHEN K,PEI Y,et al. NADPHoxidase 4 promotes endothelial angiogenesis throughendothelial nitric oxide synthase activation[J].Circulation,2011,124(6):731-740.[39] LIN K,KAZMI K S,LAW M,et al. Measuringelevated microvascular permeability and predictinghemorrhagic transformation in acute ischemic strokeusing first-pass dynamic perfusion CT imaging[J].AJNR Am J Neuroradiol,2007,28(7):1292-1298.[40] OZKUL-WERMESTER O,GUEGANMASSARDIERE,TRIQUENOT A,et al. Increasedblood-brain barrier permeability on perfusioncomputed tomography predicts hemorrhagictransformation in acute ischemic stroke[J]. EurNeurol,2014,72(1-2):45-53.[41] JAIN A R,JAIN M,KANTHALA A R,et al.Association of CT perfusion parameters withhemorrhagic transformation in acute ischemicstroke[J]. AJNR Am J Neuroradiol,2013,34(10):1895-1900.[42] BANG O Y,SAVER J L,KIM S J,et al. Collateralflow predicts response to endovascular therapy foracute ischemic stroke[J]. Stroke,2011,42(3):693-699.[43] SILLANPÄÄ N,SAARINEN J T,RUSANENH. Computed tomography angiography source images closely reflect the integrity of collateralcirculation[J]. J Neuroradiol,2015,42(5):261-268.[44] RUSANEN H,SAARINEN J T,SILLANPÄÄ N.Collateral Circulation Predicts the Size of the InfarctCore and the Proportion of Salvageable Penumbrain Hyperacute Ischemic Stroke Patients Treated withIntravenous Thrombolysis[J]. Cerebrovasc Dis,2015,40(3-4):182-190.[45] CHARIDIMOU A,PASI M,FIORELLI M,et al.Leukoaraiosis,Cerebral Hemorrhage,and OutcomeAfter Intravenous Thrombolysis for Acute IschemicStroke:A Meta-Analysis(v1)[J]. Stroke,2016,47(9):2364-2372.[46] LIN Q,LI Z,WEI R,et al. Increased Risk of Post-Thrombolysis Intracranial Hemorrhage in AcuteIschemic Stroke Patients with Leukoaraiosis:AMeta-Analysis[J/OL]. PLoS One,2016,11(4):e0153486. https://doi.org/10.1371/journal.pone.0153486.[47] DEMCHUK A M,KHAN F,HILL M D,etal. Importance of leukoaraiosis on CT for tissueplasminogen activator decision making:evaluationof the NINDS rt-PA Stroke Study[J]. CerebrovascDis,2008,26(2):120-125.[48] CONFORTO A B,LUCATO L T,LEITE CDAC,et al. Cerebral microbleeds and intravenousthrombolysis:case report[J]. Arq Neuropsiquiatr,2006,64(3B):855-857.[49] FIEHLER J,ALBERS G W,BOULANGER J M,etal. Bleeding risk analysis in stroke imaging beforethromboLysis(BRASIL):pooled analysis of T2*-weighted magnetic resonance imaging data from 570patients[J]. Stroke,2007,38(10):2738-2744.[50] PANTONI L. Cerebral small vessel disease:frompathogenesis and clinical characteristics totherapeutic challenges[J]. Lancet Neurol,2010,9(7):689-701.[51] LOU M,SAFDAR A,MEHDIRATTA M,et al. TheHAT Score:a simple grading scale for predictinghemorrhage after thrombolysis[J]. Neurology,2008,71(18):1417-1423.[52] SAPOSNIK G,FANG J,KAPRAL M K,et al. TheiScore predicts effectiveness of thrombolytic therapyfor acute ischemic stroke[J]. Stroke,2012,43(5):1315-1322.[53] MAZYA M,EGIDO J A,FORD G A,et al.Predicting the risk of symptomatic intracerebralhemorrhage in ischemic stroke treated withintravenous alteplase:safe Implementationof Treatments in Stroke(SITS)symptomaticintracerebral hemorrhage risk score[J]. Stroke,2012,43(6):1524-1531.[54] STRBIAN D,ENGELTER S,MICHEL P,et al.Symptomatic intracranial hemorrhage after strokethrombolysis:the SEDAN score[J]. Ann Neurol,2012,71(5):634-641.[55] MENON B K,SAVER J L,PRABHAKARAN S,etal. Risk score for intracranial hemorrhage in patientswith acute ischemic stroke treated with intravenoustissue-type plasminogen activator[J]. Stroke,2012,43(9):2293-2299.[56] SAPOSNIK G,GUZIK A K,REEVES M,et al.Stroke Prognostication using Age and NIH StrokeScale:SPAN-100[J]. Neurology,2013,80(1):21-28.[57] FLINT A C,FAIGELES B S,CULLEN S P,et al.THRIVE score predicts ischemic stroke outcomesand thrombolytic hemorrhage risk in VISTA[J].Stroke,2013,44(12):3365-3369.[58] HILL M D,BUCHAN A M; Canadian Alteplase forStroke Effectiveness Study(CASES)Investigators.Thrombolysis for acute ischemic stroke:results ofthe Canadian Alteplase for Stroke EffectivenessStudy[J]. CMAJ,2005,172(10):1307-1312.[59] YAGHI S,BOEHME A K,DIBU J,et al. Treatmentand Outcome of Thrombolysis-Related Hemorrhage:A Multicenter Retrospective Study[J]. JAMA Neurol,2015,72(12):1451-1457.[60] YAGHI S,WILLEY J Z,CUCCHIARA B,etal. Treatment and outcome of hemorrhagictransformation after intravenous Alteplase in acuteischemic stroke:a scientific statement for healthcareprofessionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2017,48(12):e343-e361. http://doi.org/10.1161/STR.0000000000000152. |
[1] | LU Yan, YANG Baorong, HUANG Xiangping, YANG Guangui, CHEN Shengwen, LI Jianrong, ZENG Xiaoming. MRI-Guided Thrombolysis beyond Time Window in Acute Ischemic Stroke in a County-Level Hospital: A Case-Control Study [J]. Chinese Journal of Stroke, 2022, 17(12): 1321-1326. |
[2] | SONG Yanli, LIN Jie, WU Yiping, LI Xiaojing, LIU Gaifen, XIA Wenjing, ZHANG Yuying, ZHANG Xiaolin, LYU Chenran, ZHOU Hong, LI Kai, XUE Bin, CHEN Lingling, ZHANG Zhongbo, PENG Xiao. Epidemiological Survey on the Risk Factors of Cardio-Cerebrovascular Diseases among Residents in Handan and Influencing Factors of Awareness, Treatment and Control Rate of Hypertension [J]. Chinese Journal of Stroke, 2022, 17(12): 1360-1365. |
[3] | WU Yuqian, ZHANG Yumei, FAN Xiaowei, WANG Anxin, PANG Wenbin. The Efficacy of Kinesthetic Motor Imagery Therapy for Hand Function Rehabilitation of Stroke Patients [J]. Chinese Journal of Stroke, 2022, 17(12): 1366-1371. |
[4] | YI Luo, ZHOU Hongyu, QIU Xin, LI Zixiao, WANG Yongjun. DNA Methylation Changes in Atherosclerotic Diseases [J]. Chinese Journal of Stroke, 2022, 17(11): 1163-1170. |
[5] | WANG Yubo, LI Zixiao, WANG Yongjun. Progress of the Relationship between Epigenetics and Oxidative Stress after Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1171-1177. |
[6] | CUI Lingyun, QIU Xin, ZHOU Hongyu, LI Zixiao, WANG Yongjun. Progress of the Relationship between DNA Methylation and Type 2 Diabetes [J]. Chinese Journal of Stroke, 2022, 17(11): 1183-1188. |
[7] | LIU Guangliang, HAN Kaiyue, SU Wenlong, ZHANG Hao. Effects of Aerobic Cycling Training Intensity on Motor and Cardiopulmonary Fitness in Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1203-1208. |
[8] | XU Yingxin, ZHANG Shuang, ZHOU Xiaomei, YUAN Jinglin, ZHAO Liuzhuang, YANG Haihua. Correlation of Non-Stenotic Carotid Plaque with Anterior Circulation Embolic Stroke of Undetermined Source [J]. Chinese Journal of Stroke, 2022, 17(11): 1233-1237. |
[9] | CHENG Shi, LI Jing, GUO Junping, HU Aixiang, YU Xinwei, HAN Wei, LIANG Ying, ZHANG Yuewei, JI Ruijun. Clinical Characteristics and Risk Factors of Infection in Patients with Acute Stroke during Hospitalization [J]. Chinese Journal of Stroke, 2022, 17(10): 1065-1070. |
[10] | XIANG Wei, XU Luyao, ZHANG Manman, WEI Hongchun, LIANG Zhigang. The Frequency and Influencing Factors of Asymmetrical Prominent Veins Sign on Susceptibility-Weighted Imaging in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1097-1102. |
[11] | ZHAO Yongrui, LIU Zhanhui. Progress of Diffusion Tensor Imaging in Evaluating Motor Function Prognosis of Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1114-1119. |
[12] | HAN Guangsong, NI Jun. Advances in Clinical Classification of Moyamoya Disease [J]. Chinese Journal of Stroke, 2022, 17(10): 1120-1126. |
[13] | ZHANG Boyu, GUO Yucheng, CUI Yuxia, LI Yingli, LYU Yumei. Seeking Medical Services Decision-Making Status and Relevant Influencing Factors in Patients with Acute Ischemic Stroke: A Review [J]. Chinese Journal of Stroke, 2022, 17(10): 1127-1132. |
[14] | WU Tingting, LIU Yafei, YAN Shixi, WU Yiping, ZHANG Zhongbo, ZAHNG Hanfei, FANG Pinping. Application of “Internet Plus” in Emergency Care of Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1133-1138. |
[15] | ZHANG Yige, ZHANG Wan, ZHANG Luyang, WANG Xin, DING Lan, WANG Yuying, PEI Lulu, FANG Hui, XU Yuming, SONG Bo. Association of Artery Occlusion and Recurrent Ischemic Stroke Related with Cerebral Artery Dissection [J]. Chinese Journal of Stroke, 2022, 17(09): 932-936. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||